Leica Biosystems Newcastle Ltd - Product Owner Profile
Explore comprehensive product owner profile for Leica Biosystems Newcastle Ltd through Pure Global AI's free Singapore medical device database. This company owns 40 medical devices registered with HSA across 2 device classes. Their registration history spans from Nov 01, 2011 to Apr 17, 2025.
This page provides detailed insights including recent registrations, device class distribution (CLASS C IVD: 19, CLASS B IVD: 21), and complete regulatory information from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry.
Free Owner Profile
Powered by Pure Global AI
40 Devices
2 Device Classes
Leica Biosystems Newcastle Ltd
Product Owner
40
Total Devices
2
Device Classes
2011
Earliest
2025
Latest
Recent Registrations
Latest 10 HSA device registrations
Leica BOND Ready-to-Use Primary Antibody Mammaglobin (EP249)
DE0510604
CLASS C IVD
Apr 17, 2025
Leica BOND Ready-to-Use Primary Antibody Immunochemistry Antibody (Other Cancer Markers)
DE0510441
CLASS B IVD
Mar 08, 2025
Leica Novocastra™ Immunohistochemistry Antibody (Hematologic Disorder and Blood Cancer Markers)
DE0509465
CLASS B IVD
Jun 27, 2024
Leica BOND Ready-to-Use ISH CMV Probe
DE0507323
CLASS C IVD
Sep 30, 2022
Leica Bond Ready to Use Primary Antibody Human Chorionic Gonadotrophin (Polyclonal)
DE0507155
CLASS B IVD
Aug 10, 2022
Leica Novocastra™ Immunohistochemistry Antibody (Other cancer markers)
DE0506051
CLASS B IVD
Aug 06, 2021
Leica BOND Ready-to-Use ISH Probe (FISH -Hematologic Disorder and Blood Cancer Markers)
DE0505841
CLASS B IVD
Jun 03, 2021
Leica Bond Ready-to-Use Primary Antibody S-100 (EP32)
DE0505754
CLASS B IVD
May 05, 2021
Leica Novocastra Liquid Rabbit Monoclonal Antibody S-100 (EP32)
DE0505755
CLASS B IVD
May 05, 2021
Leica BOND Ready To Use Primary Antibodies Immunohistochemistry (IHC- Hematologic Disorder and blood cancer marker)
DE0505428
CLASS B IVD
Feb 03, 2021
Device Class Distribution
Devices by class
CLASS B IVD
21
52.5% of total
CLASS C IVD
19
47.5% of total